Press Releases Helius Medical Technologies, Inc.

Equities

HSDT

US42328V8019

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
1.63 ^USD	-4.12%		-43.21%	-79.72%

05-07	Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Traders Assess Earnings	MT
05-07	Top Premarket Decliners	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)	05-06	AQ
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation	04-25	AQ
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024	03-15	AQ
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke	03-12	AQ
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference	03-07	AQ
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller	03-04	AQ
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS	02-05	AQ
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results	11-09	AQ
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work	11-06	AQ
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024	11-02	AQ
Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices	12/10/23	AQ
Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences	02/10/23	AQ
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece	28/09/23	AQ
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference	21/09/23	AQ
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery	20/09/23	AQ
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference	13/09/23	AQ
Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria	05/09/23	AQ
Helius Medical Technologies Announces Reverse Stock Split	16/08/23	AQ
Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program	07/08/23	AQ
Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023	02/08/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Helius Medical Technologies, Inc.

Equities

HSDT

US42328V8019

Press Releases

Filters